5 WAYS TO MAINTAIN CLINICAL STUDY COMPLIANCE DURING COVID-19
The FDA recently released guidance to help sponsors and sites protect human subjects while keeping their trial moving forward.
Based on those recommendations and our own experience, we've put together a short list of five next steps you can take as you navigate this new territory.
